BAJAJ BROKING

Notification close image
No new Notification messages
card image
Amanta Healthcare Ltd IPO
Apply for the Amanta Healthcare Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

531210

COLINZ

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

COLINZ LABORATORIES LTD. Share Price Update

As of the latest trading session, COLINZ LABORATORIES LTD. share price is currently at ₹ 43.38, which is up by ₹ 1.63 from its previous closing. Today, the stock has fluctuated between ₹ 39.77 and ₹ 43.83. Over the past year, COLINZ LABORATORIES LTD. has achieved a return of -25.24 %. In the last month alone, the return has been -4.08 %. Read More...

Investment Returns

Over 1 Month -4.08% Over 3 Months -35.15% Over 6 Months -4.33% Over 1 Year -25.24%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

COLINZ LABORATORIES LTD. fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    19.80

  • P/E Ratio (TTM)

    39.76

  • Beta

    0.55

  • Book Value / share

    25.21

  • Return on equity

    5.43%

  • EPS (TTM)

    1.05

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    0.12

info icon alternate text

COLINZ LABORATORIES LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2025 (Values in Cr)
Revenue 1.57
Operating Expense 1.48
Net Profit 0.12
Net Profit Margin (%) 7.64
Earnings Per Share (EPS) 0.47
EBITDA 0.21
Effective Tax Rate (%) 25.00
Particulars MAR 2025 (Values in Cr)
Revenue 1.45
Operating Expense 1.41
Net Profit 0.15
Net Profit Margin (%) 10.34
Earnings Per Share (EPS) 0.60
EBITDA 0.16
Effective Tax Rate (%) -25.00
Particulars DEC 2024 (Values in Cr)
Revenue 1.47
Operating Expense 1.45
Net Profit 0.05
Net Profit Margin (%) 3.40
Earnings Per Share (EPS) 0.21
EBITDA 0.14
Effective Tax Rate (%) 50.00
Particulars SEP 2024 (Values in Cr)
Revenue 1.86
Operating Expense 1.73
Net Profit 0.16
Net Profit Margin (%) 8.60
Earnings Per Share (EPS) 0.62
EBITDA 0.25
Effective Tax Rate (%) 23.80
Particulars JUN 2024 (Values in Cr)
Revenue 1.75
Operating Expense 1.63
Net Profit 0.14
Net Profit Margin (%) 8.00
Earnings Per Share (EPS) 0.54
EBITDA 0.22
Effective Tax Rate (%) 27.77
Particulars MAR 2025 (Values in Cr)
Revenue 6.53
Operating Expense 6.20
Net Profit 0.50
Net Profit Margin (%) 7.65
Earnings Per Share (EPS) 1.97
EBITDA 0.79
Effective Tax Rate (%) 19.35
Particulars MAR 2024 (Values in Cr)
Revenue 7.03
Operating Expense 6.66
Net Profit 0.49
Net Profit Margin (%) 6.97
Earnings Per Share (EPS) 1.93
EBITDA 0.82
Effective Tax Rate (%) 24.61
Particulars MAR 2023 (Values in Cr)
Revenue 7.15
Operating Expense 6.72
Net Profit 0.46
Net Profit Margin (%) 6.43
Earnings Per Share (EPS) 1.82
EBITDA 0.78
Effective Tax Rate (%) 23.33
Particulars MAR 2022 (Values in Cr)
Revenue 6.97
Operating Expense 6.67
Net Profit 0.34
Net Profit Margin (%) 4.87
Earnings Per Share (EPS) 0.74
EBITDA 0.76
Effective Tax Rate (%) 29.16
Particulars MAR 2021 (Values in Cr)
Revenue 6.16
Operating Expense 6.10
Net Profit 0.21
Net Profit Margin (%) 3.40
Earnings Per Share (EPS) 0.45
EBITDA 0.53
Effective Tax Rate (%) 16.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 37.61
ROE % 5.43
ROCE % 6.72
Total Debt to Total Equity 0.07
EBITDA Margin 12.10
Particulars MAR 2024 (Values in Cr)
Book Value / Share 35.52
ROE % 5.73
ROCE % 7.70
Total Debt to Total Equity 0.05
EBITDA Margin 11.66
Particulars MAR 2023 (Values in Cr)
Book Value / Share 32.31
ROE % 5.81
ROCE % 7.82
Total Debt to Total Equity 0.05
EBITDA Margin 10.91
Particulars MAR 2022 (Values in Cr)
Book Value / Share 21.69
ROE % 4.54
ROCE % 6.78
Total Debt to Total Equity 0.10
EBITDA Margin 10.90
Particulars MAR 2021 (Values in Cr)
Book Value / Share 20.57
ROE % 2.97
ROCE % 4.36
Total Debt to Total Equity 0.10
EBITDA Margin 8.60
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 5.55
Total Assets 11.81
Total Liabilities 11.81
Total Equity 9.47
Share Outstanding 2519100
Price to Book Ratio 1.93
Return on Assets (%) 4.20
Return on Capital (%) 4.91
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 7.00
Total Assets 11.35
Total Liabilities 11.35
Total Equity 8.94
Share Outstanding 2519100
Price to Book Ratio 1.06
Return on Assets (%) 4.28
Return on Capital (%) 5.11
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 5.72
Total Assets 10.23
Total Liabilities 10.23
Total Equity 8.13
Share Outstanding 2519100
Price to Book Ratio 1.08
Return on Assets (%) 4.47
Return on Capital (%) 5.44
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 5.20
Total Assets 9.93
Total Liabilities 9.93
Total Equity 7.68
Share Outstanding 4571000
Price to Book Ratio 1.09
Return on Assets (%) 3.41
Return on Capital (%) 4.15
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 4.68
Total Assets 10.10
Total Liabilities 10.10
Total Equity 7.29
Share Outstanding 4571000
Price to Book Ratio 0.37
Return on Assets (%) 2.05
Return on Capital (%) 2.51
Particulars MAR 2025 (Values in Cr)
Net Income 0.61
Cash from Operations -1.24
Cash from Investing -0.23
Cash from Financing 0.23
Net change in Cash -1.45
Free Cash Flow -0.98
Particulars MAR 2024 (Values in Cr)
Net Income 0.65
Cash from Operations 1.21
Cash from Investing 0.00
Cash from Financing 0.22
Net change in Cash 1.27
Free Cash Flow 1.21
Particulars MAR 2023 (Values in Cr)
Net Income 0.59
Cash from Operations 0.56
Cash from Investing 0.00
Cash from Financing 0.11
Net change in Cash 0.52
Free Cash Flow 0.56
Particulars MAR 2022 (Values in Cr)
Net Income 0.48
Cash from Operations 0.61
Cash from Investing -0.03
Cash from Financing 0.09
Net change in Cash 0.52
Free Cash Flow 0.65
Particulars MAR 2021 (Values in Cr)
Net Income 0.24
Cash from Operations 2.23
Cash from Investing -0.15
Cash from Financing 0.08
Net change in Cash 2.08
Free Cash Flow 2.39
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 31.16 12.72 1.70 238.79 30.00 / 69.50
BLISS GVS PHARMA LTD 158.10 15.64 1.58 1667.92 105.05 / 190.65
CIPLA LTD 1587.60 23.78 4.11 128239.04 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 322.55 9.08 2.61 949.30 219.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2804.55 50.17 24.34 47510.77 1924.30 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 31.16 16.93 4.92 238.79 30.00 / 69.50
AMRUTAJAN HEALTH LTD 720.55 38.21 6.37 2083.16 548.05 / 838.00
ASTRAZENECA PHARMA IND LT 8751.75 103.46 28.40 21879.38 6222.35 / 10653.05
BLISS GVS PHARMA LTD 158.10 23.63 1.57 1667.92 105.05 / 190.65

COLINZ LABORATORIES LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
43.38 3.90 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 40.90
  • 26 Days 43.30
  • 10 Days 41.50
  • 50 Days 45.60
  • 12 Days 41.70
  • 100 Days 49.20
  • 20 Days 42.70
  • 200 Days 52.00
40.54 PIVOT

First Support

39.34

First Resistance

42.96

Second Support

36.92

Second Resistance

44.16

Third Support

35.72

Third Resistance

46.58

RSI

41.53

ADX

61.30

MACD

-1.52

Williams % R

-39.97

Commodity Channel Index (CCI)

-100.11

Date

2025-09-01

Week

2137.00

Same Day

1263.00

Month

825.00

1 Year

0.55

3 Year

0.49

Over 1 Month

-4.08%

down

Over 1 Year

-25.24%

down

Over 3 Months

-35.15%

down

Over 3 Years

7.13%

down

Over 6 Months

-4.33%

down

Over 5 Years

37.48%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

COLINZ LABORATORIES LTD. shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Name Shares Category

News

Left Arrow
Right Arrow

COLINZ LABORATORIES LTD. corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

COLINZ LABORATORIES LTD. Share Price

Colinz Laboratories Limited, was incorporated as a Private Limited Company in 1986. The Company got converted into Public Limited Company in 1995, which however started their manufacturing and marketing activities in 1995. The Company manufactures a wide variety of pharmaceutical formulations in the dosage forms of tablets, capsules, granules, liquid orals, injectables, ointments, creams etc. The Company is having certain specialized products for Gynaecology, Cardiology, Gastroentrology etc. Since, the Company falls under the MSME sector, it established reputation as a quality supplier of medicines in the domestic market, wherever the Company has operation.

Apart from this, the Company has a WHO compliant plant at Sinnar. Apart from a modern plant, it has its own well equipped quality control laboratory. The technical team is headed by a Vice President (works), Plant Manager & Production Manager etc. They are highly qualified and FDA approved expert staff with over two decades of experience in manufacturing and development of a number of products for various therapeutic segments. The Company's products are enjoying a good Brand image, particularly among gynaecologists. The Company has potential to grow considering the fact that it is yet to open up its marketing operations in many states of the country, which is kept on hold due to general economic situation.

Parent organization Indian Private
NSE symbol [-]
Founded 1986
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Colinz Laboratories Ltd?

Answer Field

Colinz Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 43.38 as on Sep 02 2025 03:17 PM.

What is the Market Cap of Colinz Laboratories Ltd Share?

Answer Field

The market cap of Colinz Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 19.80 as on Sep 02 2025 03:17 PM.

What is the 52 Week High and Low of Colinz Laboratories Ltd?

Answer Field

The 52 Week High and Low of Colinz Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 88.70 and ₹ 37.87.

What is 1 year return for Colinz Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been -25.24%.

What is the P/E Ratio of Colinz Laboratories Ltd Share?

Answer Field

As on Sep 02 2025 03:17 PM the price-to-earnings (PE) ratio for Colinz Laboratories Ltd share is 39.76.

What is the PB ratio of Colinz Laboratories Ltd Share?

Answer Field

As on Sep 02 2025 03:17 PM, the price-to-book (PB) ratio for Colinz Laboratories Ltd share is 25.21.

How to Buy Colinz Laboratories Ltd Share?

Answer Field

You can trade in Colinz Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Colinz Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Colinz Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Colinz Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-image

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91